Possible linkages between the inner and outer cellular states of human induced pluripotent stem cells by Saito, Shigeru et al.
REPORT Open Access
Possible linkages between the inner and outer
cellular states of human induced pluripotent
stem cells
Shigeru Saito
1,2†, Yasuko Onuma
3†, Yuzuru Ito
3†, Hiroaki Tateno
4†, Masashi Toyoda
5†, Akutsu Hidenori
5,
Koichiro Nishino
5, Emi Chikazawa
5, Yoshihiro Fukawatase
5, Yoshitaka Miyagawa
6, Hajime Okita
6,
Nobutaka Kiyokawa
6, Yohichi Shimma
4, Akihiro Umezawa
5, Jun Hirabayashi
4, Katsuhisa Horimoto
1,7*,
Makoto Asashima
3,8*
From The 4th International Conference on Computational Systems Biology (ISB 2010)
Suzhou, P. R. China. 9-11 September 2010
Abstract
Background: Human iPS cells (hiPSCs) have attracted considerable attention for applications to drug screening
and analyses of disease mechanisms, and even as next generation materials for regenerative medicine. Genetic
reprogramming of human somatic cells to a pluripotent state was first achieved by the ectopic expression of four
factors (Sox2, Oct4, Klf4 and c-Myc), using a retrovirus. Subsequently, this method was applied to various human
cells, using different combinations of defined factors. However, the transcription factor-induced acquisition of
replication competence and pluripotency raises the question as to how exogenous factors induce changes in the
inner and outer cellular states.
Results: We analyzed both the RNA profile, to reveal changes in gene expression, and the glycan profile, to identify
changes in glycan structures, between 51 cell samples of four parental somatic cell (SC) lines from amniotic
mesodermal, placental artery endothelial, and uterine endometrium sources, fetal lung fibroblast (MRC-5) cells, and
nine hiPSC lines that were originally established. The analysis of this information by standard statistical techniques
combined with a network approach, named network screening, detected significant expression differences between
the iPSCs and the SCs. Subsequent network analysis of the gene expression and glycan signatures revealed that the
glycan transfer network is associated with known epitopes for differentiation, e.g., the SSEA epitope family in the
glycan biosynthesis pathway, based on the characteristic changes in the cellular surface states of the hiPSCs.
Conclusions: The present study is the first to reveal the relationships between gene expression patterns and cell
surface changes in hiPSCs, and reinforces the importance of the cell surface to identify established iPSCs from SCs.
In addition, given the variability of iPSCs, which is related to the characteristics of the parental SCs, a
glycosyltransferase expression assay might be established to define hiPSCs more precisely and thus facilitate their
standardization, which are important steps towards the eventual therapeutic applications of hiPSCs.
* Correspondence: k.horimoto@aist.go.jp; m-asashima@aist.go.jp
† Contributed equally
1Computational Biology Research Center, National Institute of Advanced
Industrial Science Technology (AIST), 2-4-7 Aomi, Koto-ku, Tokyo 135-0064,
Japan
3Research Center for Stem Cell Engineering, National Institute of Advanced
Industrial Science Technology (AIST), Tsukuba Central 4, 1-1-1 Higashi,
Tsukuba, Ibaraki 305-8562, Japan
Full list of author information is available at the end of the article
Saito et al. BMC Systems Biology 2011, 5(Suppl 1):S17
http://www.biomedcentral.com/1752-0509/5/S1/S17
© 2011 Saito et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Background
Reprogramming of human and mouse fibroblasts to
induced pluripotent stem cells (iPSCs) has been
achieved by the expression of only four transcription
factors, Oct4, Sox2, Klf4, and c-Myc, referred to as the
“four factors” [1]. iPSCs hold great promise for human
disease analyses and therapies, because they are highly
similar to embryonic stem cells (ESCs) in their ability to
self-renew and generate all three germ layers. A key
question raised by transcription factor-induced repro-
gramming to self-renewal and pluripotency is how the
four factors act to accomplish these changes in the
inner and outer cell states.
The morphological changes accompanying the repro-
gramming of somatic cells to iPSCs can be visually iden-
tified by alkaline phosphatase staining. The changes in
the outer cellular states are further monitored by char-
acteristic molecular markers. In fact, the monoclonal
antibodies currently used to define ESCs and iPSCs,
including the globo-series glycosphingolipid epitopes
SSEA-3 and SSEA-4, and the keratanase-sensitive glyco-
protein associated epitopes Tra 1–60 and Tra 1–81,
recognize glycan antigens [2-4]. Recently, global analyses
of glycan signatures for pluripotency on the cell surface
were reported, by direct observations of glycan struc-
tures by MALDI-TOF mass spectrometric and NMR
spectrometric profiling in ESCs [5] and indirect observa-
tions of lectins by a lectin microarray in stem cells [6].
Furthermore, the extracellular matrix is also important
for controlling cellular states through cell-cell interac-
tions [7].
The inner cellular states also change during the remo-
deling of the somatic cell transcription and chromatin
programs to the ES-like state, including the reactivation
of the somatically silenced X chromosome, the demethy-
lation of the Oct4 and Nanog promoter regions, and the
genome-wide resetting of histone H3 lysine 4 and 27 tri-
methylation [8]. It is particularly important to determine
whether the gene expression differences observed
between hiPSCs and the corresponding parental cells
actually reflect the differences between these pluripotent
cell types, especially between hiPSCs and ESCs [9-12].
Gene expression signatures were reported for repro-
grammed cell lines derived in different labs by various
methods [13-15]. In addition, genome-wide mapping of
transcription factor targets by ChIP, combined with
microarrays or sequencing methods, can provide a foun-
dation for understanding transcriptional networks
[16-20]. Expanding the number of transcription factors
analyzed by ChIP-based methods is especially informa-
tive in dissecting system level biological processes. In
ESCs, some groups have used new methods for global
target mapping to predict the target genes regulated by
Oct4, Sox2, and Nanog, and these studies revealed the
combinatorial occupancy of target gene promoters by
these core factors, as well as both autoregulatory and
feed-forward transcriptional circuits [16-20].
Here, we applied two methods, RNA profiling to
uncover gene expression changes, and lectin profiling to
survey glycan structure changes, to compare human
iPSCs and parental somatic cells (SCs), including 51
cells of nine iPSC lines from four kinds of SCs, from
amniotic mesodermal, placental artery endothelial, and
uterine endometrium sources, and one available hiPSC
line, MRC-5. The changes were computationally ana-
lyzed by a network approach [21] in conjunction with
information on the gene binding from previous CHIP-
seq studies and knowledge of the gene functions. The
sum of these analyses uncovered novel expression, net-
work, and lectin signatures that are unique to the hiPSC
lines and differ from those of the parental cells. The fol-
lowing correspondence between the three signatures
identified a few glycosyltransferases as novel candidates,
due to the characteristic changes of their cellular surface
states in hiPSCs, which shed light on a possible link
between the inner and outer cellular states. Whether the
hiPSC signatures described here actually play a func-
tional role in bridging the gap between the two cellular
states warrants extensive further investigations.
Results and Discussion
hiPSCs descended from different parent SCs are
distinguishable by gene expression
To determine the gene expression signatures of hiPSCs,
a detailed genome-wide expression analysis was per-
formed to compare iPSCs and their parental SCs from
amniotic mesodermal (AM), placental artery endothelial
(PAE), uterine endometrium (UtE), and MRC-5 (MRC)
cell sources (see additional file 1: Cell lines and numbers
of passages analyzed in the present study, and Methods).
In total, 51 cell samples of 13 cell lines (39 hiPSC sam-
ples of 9 hiPSC lines [22,23]) were analyzed in the pre-
sent study, for a statistical comparison of the hiPSCs
and the parental SCs (see additional file 2: Generation
of iPSCs from human PAE cells).
Unsupervised hierarchical clustering of the gene
expression data across the four hiPSC lines (AM, PAE,
UtE, MRC) and their corresponding parental SCs
revealed interesting patterns in the gene expression heat
map (Fig. 1A). First, the hiPSCs were clearly distinguish-
able from their respective parental SCs. This finding was
verified by another clustering method with a distinct
technique (see additional file 3: Clustering of the gene
expression data with another method). Second, the gene
expression profiles of the four hiPSC lines were linked
to those of their parental SCs, while these profiles of the
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sely with each other, rather than with those of the
hiPSCs from the corresponding parental SCs (Fig. 1A).
In support of these findings, a Pearson correlation ana-
lysis demonstrated that the gene expression profiles of
t h eh i P S C sf r o md i f f e r e n tp a s s a g e sw e r em o r ec l o s e l y
related to each other than to the hiPSCs from the same
parental SCs (Fig. 1B and see also additional file 4: Cor-
relation coefficient matrix for all cells). Furthermore, the
above relationship between the hiPSCs and the parental
SCs was verified by estimating the classification accuracy
by leave-one-out cross-validation (LOOCV) on the near-
est-neighbor classifier, based on Pearson’sc o r r e l a t i o n
distance (see additional file 5: Cross validation of cell
classification).
Gene expression signature for hiPSCs descended from
different parent SCs
Analyses of the differences in gene expression between
the four hiPSC lines and the parental SC lines revealed
that 8,287 (out of 16,483) genes in the AM cells, 7,249
genes in the MRC cells, 7,465 genes in the PAE cells,
and 6,314 genes in the UtE cells showed significant dif-
ferences between the hiPSC lines and the corresponding
parental lines, as determined using the Student’s t-test
(for a false discovery rate [FDR] < 5% and requiring a
≥2.0-fold change in expression between the cells) (Fig.
2A). In total, 2,502 genes were categorized into a gene
expression signature common to the above four gene
sets with expression differences (Fig. 2B and see also
additional files 6: Number matrix for common genes,
and 7: List of 2,502 genes in the expression signature,
together with the fold-changes in expression levels and
FDR values).
In this expression signature, 62% of the genes (1,549
genes) were upregulated and 38% (953 genes) were
downregulated in the hiPSCs, as compared to the paren-
tal SCs (Fig. 2B and see also additional file 7). From the
953 genes in the gene signature that were expressed at
lower levels, gene ontology analyses revealed 60 terms
with significant probability (family-wise error rate
[FWER] <0.05), whereas the 1,549 genes that were
expressed at higher levels were characterized by 89
terms (see additional file 8: List of enriched GO terms
with significant probabilities (FWER < 0.05)). In total,
149 terms were found, and the GO analysis was deter-
mined to be inadequate for defining the biological func-
tions of the expression signature in hiPSCs. The 149
terms were summarized into 33 terms as a macroscopic
view; these terms shared 9 terms between the higher
and lower expression levels (Fig. 2C).
Network signature of hiPSCs by network screening
To elucidate the nature of the expression signature of the
hiPSCs, we incorporated information on gene binding and
function into a network analysis approach, named network
screening [21] (see additional file 9: Schematic representa-
tion of the network screening used to obtain the network
signature, and Methods). To prepare the network analysis,
we identified 146 regulatory networks of 313 genes in the
expression signature, which were classified with their func-
tions using the gene sets defined previously [24] (see addi-
tional file 10: Reference networks and constituent genes,
and Methods), among 519 genes that were identified as
being bound by the four factors in ChIP-on-chip experi-
ments [20]. We then analyzed the 146 reference networks,
which were regarded as being directly induced by the four
factors (OCT3/4, SOX2, KLF4, c-MYC), to define the
Figure 1 Classification of hiPSCs and SCs from gene expression data (A) Heat map and hierarchical clustering for all cells and genes. Cell
types are indicated by colored bars, and the following abbreviations are used for the sources of the cell types of the human somatic cells (SCs)
and induced pluripotent stem cells (hiPSCs): AM, amniotic membrane cell; PAE, placental artery cell; UtE, uterine endometrium cell; MRC, MRC-5
cell. Details are available in additional file 1. (B) Heat map of the correlation coefficient matrix for all of the cells. See also additional file 3.
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ing two thresholds (Fig. 3): 1) the enrichment probability
of the genes in the expression signature for each network;
and 2) the consistency of the network structure in relation
to the gene expression profile [21]. Thus, as the network
signature, we defined 28 networks of 76 genes that fulfilled
these conditions (Fig. 3A and see also additional file 11:
Details of the network signature).
As expected, the network signature almost completely
covered the pathways that were previously implicated in
the reprogramming of hiPSC pluripotency (Figs. 3A and B
). For example, the relationship between reprogramming
for pluripotency and signal transduction was emphasized
for the TGF-b [25], Wnt [26], and MAPK pathways [27].
In addition, pathways related to cell-cell interactions were
implicated. Although the molecular mechanisms underly-
ing the cell-cell interactions in the inner cellular states are
less understood, several studies have highlighted the
importance of cellular communication through the extra-
cellular matrix with respect to changes in the cellular
states, such as those that occur during development and
differentiation [28]. Furthermore, relationships to cancer-
related pathways were identified, consistent with the fact
that the four factors induce various cancer cells [29]; this
finding may be useful in the prevention of cancer induc-
tion by hiPSCs. Although several pathways in the network
signature remain to be characterized, it provides clues as
to the molecular mechanisms underlying the reprogram-
ming for hiPSC pluripotency and self-renewal, in contrast
to the information obtained from a characterization based
simply on GO terms.
Networks with significant correlation between
reprogramming and glycan biosynthesis
Interestingly, two regulatory networks related to the gly-
come, for linkage of the inner and outer cellular states,
Figure 2 Gene expression signature (A) Heat map of 2,502 genes in the hiPSCs and parental cells. Cell types are indicated by colored bars. (B)
Heat maps for the MRC, AM, UtE, and PAE hiPSCs and their corresponding parental cells. The hiPSCs and the parental SCs are discriminated by
colored bars (red, SCs; purple, hiPSCs). (C) GO terms in the Biological Process, with the significance probabilities for the genes with higher and
lower levels of expression. GO terms were summarized into 33 terms, as a macroscopic view, and the overlapped terms in the higher and lower
expression classes are indicated by bold characters. See also additional file 6.
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categories: orange, pathways related to signal transduction; blue, pathways related to cell-cell interactions; red, pathways related to glycan
biosynthesis; green, pathways related to cancer; and black, unclassified pathways. (B) Schematic presentation of networks. The four induced
factors are described in the center, and the binding genes, which are colored according to the classification scheme described in (A), are
connected by thin lines.
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glycan biosynthesis is a multi-step process that requires
a variety of enzymes, i.e., glycosyltransferases and
enzymes involved in cytosolic sugar metabolism, and in
many cases, glycan biosynthesis follows a glycan-specific,
linear pathway. Most glycosyltransferases are regulated
at the transcriptional level, thus warranting an assess-
ment of the transcriptional profile of the glycan bio-
synthesis genes. In the two pathways, we found three
genes (ST6GAL1, B3GNT3,a n dGCNT2) related to gly-
can transfer and two genes (EXT1 and HS6ST2) related
to heparan sulfate biosynthesis that were included in the
expression signature (Fig. 4). These findings are consis-
tent with recent studies that revealed the association
between N-glycans and the maintenance of embryonic
stem cell (ESC) pluripotency [5] and that between
heparan sulfate and the reprogramming of ESCs [30].
Therefore, the genes identified in the above two path-
ways are candidates for the maintenance of the outer
cellular state of iPSCs.
Glycan signature unique to hiPSCs
In addition to the expression and network signatures of
the inner cell state, we examined the differences in the
outer cellular states of the hiPSCs and the parental SCs
using a lectin array, which detects glycan structures on
cell surface proteins, based on glycan-lectin interactions
[31]. In this analysis, the hiPSCs were clearly distinct
from their parental SCs, and the dendrogram of the lectin
microarray generated by unsupervised hierarchical clus-
tering showed a clear separation between the hiPSCs and
the parental SCs (Fig. 5A). Although the binding relation-
ships between lectins and glycans and the relationships
between the changes in glycan structures and the corre-
sponding glycosyltransferases are redundant [32], we
summarized the lectin-glycan-glycosyltransferase rela-
tionships using KEGG GLYCAN [33] and by manual
curation of previous reports. We found strong correla-
tions between the gene expression profiles of the glyco-
syltransferases and the corresponding lectin fluorescence
intensities (see additional file 12: Lectin-glycan-glycosyl-
transferase relationships and correlations of lectin array
intensities with glycosyltransferase expression patterns).
This result indicates that the glycosyltransferases are
coordinately expressed with the reprogramming, with the
result that the hiPSCs bear glycan structures that are dis-
tinct from those of their parental SCs, reflecting the
reprogramming of the inner cellular state.
Based on the Student’s t-test (FDR <0.05) analysis, 28
of the 43 lectins in the lectin microarray showed signifi-
cant differences between the hiPSCs and the parental
SCs (see also additional file 12). For the glycan signa-
ture, we assigned 16 lectins, which interacted with the
12 glycosyltransferases that were related to the six pat-
terns of glycan reactions, based on the correspondence
with the expression signature (Fig. 5B).
Figure 4 Genes involved in two glycome biosynthesis pathways The genes found in the expression signature are indicated by bold
characters. Three genes related to glycan transfer are indicated by asterisks.
Figure 5 Glycan signature (A) Heat map and hierarchical
clustering of lectins. The hiPSCs and parental SCs are depicted by
colored bars (red, SCs; purple, hiPSCs). (B) Correspondence between
lectin gene expression patterns and glycan signatures. The lectin-
glycosyltransferase relationships are described, together with their
reactions. The lectins were selected under the condition that the
corresponding glycosyltransferases were found in the expression
signature.
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outer cellular states
Based on the correspondences between the expression
and network signatures and between the expression and
glycan signatures, we identified a total of 14 glycosyl-
transferases, since ST6GAL1 appeared in both sets of
correspondences. These glycosyltransferases are poten-
tial candidates for the linkage between the inner and
outer cellular states in hiPSCs. Interestingly, these glyco-
syltransferases may be related to the biosynthesis of a
glycolipid that is characteristic of hiPSCs (see additional
file 13: Knowledge-based relationships between glycosyl-
transferases and their biosynthetic pathways). Indeed,
the allocation of the above glycosyltransferases to the
pathways of “Glycan Biosynthesis and Metabolism” in
KEGG GLYCAN (Table 1 and see also additional file
14: Locations of the glycosyltransferases detected in the
present study in the pathways of “Glycan Biosynthesis
and Metabolism”) revealed that the glycosyltransferases
identified in the present study are important in the gly-
colipid biosynthetic pathway. We identified B3GALT5 in
the biosynthetic pathway for the carbohydrate chains of
the globo-series of glycosphingolipids bearing the well-
known SSEA-3 and SSEA-4 epitopes for ESCs and
iPSCs [34,35], and although FUT2 is not directly
involved in the synthesis of these glycans, it was found
in the neighboring pathway that leads to the type IV H
antigen. Furthermore, B3GALT1 and GCNT2, in addi-
tion to B3GALT5 and FUT2, were found in the exten-
sive biosynthetic pathway of the carbohydrate chains of
the lacto- and neolacto-series glycosphingolipids that
carry SSEA-1, which is intensively expressed in ESCs,
but is absent in cells that have differentiated from ESCs
[36]. In addition, the members of the GALNT family,
responsible for the O-glycan biosynthetic pathway of sia-
lyl-T antigen, which is the most abundant glycan in sev-
eral carcinoma cell lines, and ST6GAL1 were only
found in the N-glycan biosynthetic pathway, which is
involved in the generation of cell-surface carbohydrate
determinants and the differentiation antigens HB-6,
CDw75, and CD76 [37]. These analyses identified the
glycosyltransferases that are directly and indirectly
related to known glycan epitopes, thereby indicating the
key molecules and the marker epitopes involved in
reprogramming.
Further remarks on the present study
We analyzed more than 50 hiPSCs that were originally
established from parental SCs, and the correspondence
between each hiPSC and its parental SC was strictly
controlled, which supports the present results based on
a comparison with a clear genetic relationship. To
further clarify the molecular mechanisms of the pluripo-
tency, embryonic stem cells (ESCs) should be analyzed,
following the context of the present study. Indeed, the
pluripotency of hiPSCs has been extensively evaluated
with reference to that of human ESCs, by various com-
parisons [38-43]. At present, we have prepared more
than 100 hiPSCs with higher passages, and their com-
parisons with ESCs will be reported in the near future.
As for the experimental measurements, two types of
data, gene expression and glycan structure, were ana-
lyzed by using microarrays and lectin arrays in the pre-
sent study. To comprehensively understand the features
of hiPSCs, more experimental data should be utilized,
such as DNA-methylation and mi-RNA data. In particu-
lar, the recent availability of the next-gen sequencer will
produce RNA-seq and ChIP-seq data with more
Table 1 Relationships between glycosyltransferase expression, network, and glycan signature
Glycosyltransferase Functions Glycan structure
ST6GAL1 N-, O-Glycan and glycolipid biosynthesis Siaa2,6Galb1,4GlcNAc-R
B3GNT3 O-Glycan biosynthesis core1 extension
GCNT2 N-, O-Glycan and glycolipid biosynthesis I antigen Siaa2,3Galb1,3GalNAca1-
ST3GAL1 O-Glycan biosynthesis Ser/Thr
FUT2 N-, O-Glycan and glycolipid biosynthesis H antigen
GALNT6 O-Glycan biosynthesis GalNAca1-Ser/Thr
GALNT8 O-Glycan biosynthesis GalNAca1-Ser/Thr
GALNT10 O-Glycan biosynthesis GalNAca1-Ser/Thr
GALNT12 O-Glycan biosynthesis GalNAca1-Ser/Thr
GALNT14 O-Glycan biosynthesis GalNAca1-Ser/Thr
GALNTL2 Unknown
B3GALT5 N-, O-Glycan and glycolipid biosynthesis Galb1,3GlcNAc-R, SSEA-3
B3GALT1 N-, O-Glycan and glycolipid biosynthesis N- and O-Glycan, keratan sulfate Galb1,3GlcNAc-R
B3GNT2 biosynthesis polylactosamine
The fourteen glycosyltransferases with identified correspondences between expression, network, and glycan signatures were allocated to biosynthetic pathways,
using the KEGG GLYCAN database with modifications. The names of the pathways are listed. See also additional file 12 for the detailed pathways of notable
glycosyltransferases, according to the KEGG GLYCAN database.
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information about the regulated genes. In addition, vast
amounts of protein interaction data are accumulating. A
comprehensive analysis integrating the various data
from more hiPSCs will be reported in the near future.
Conclusions
The present study is the first to reveal the relationships
between gene expression patterns and cell surface
changes in hiPSCs, and it reinforces the importance of
the cell surface to identify established iPSCs from SCs.
In addition, given the variability of iPSCs, which is
related to the characteristics of the parental SCs, a gly-
cosyltransferase expression assay should be established
that allows more precise definition of hiPSCs and facili-
tates their standardization, which are important steps
towards eventual therapeutic applications of hiPSCs.
Methods
Cell experiments
Somatic cell pellets were harvested by scraping. The
hiPSCs were incubated at 37°C, in a solution containing
1 mg/ml collagenase IV (Invitrogen, Carlsbad, CA), 1
mM CaCl2, 20% KNOCKOUT
TM Serum Replacement
(KSR), and 10% ACCUMAX (Innovative Cell Technolo-
g i e s ,I n c . ,S a nD i e g o ,C A ) .W h e nt h ee d g e so ft h ec o l o -
nies started to dissociate from the bottom of the dish,
the collagenase solution was removed and the cells were
washed with medium. Colonies were then picked up
and collected.
MRC-5 and amniotic mesodermal (AM) cells were
maintained in POWEREDBY 10 medium (MED Shira-
tori Co., Ltd., Tokyo, Japan). The human placental
artery endothelial (PAE) cells were harvested from
human placenta. To isolate the arterial endothelium, we
used the explant culture method, in which the cells
were outgrown from pieces of the placenta’s arterial ves-
sels. Briefly, arterial vessels were separated from arteries
in the chorionic plate, and chopped into approximately
5-mm
3 pieces. The pieces were washed in endothelial
basal medium-2 (EBM-2; Cambrex, Walkersville, MD)
and cultured in EGM-2MV medium (Cambrex), which
consisted of EBM-2, 5% fetal bovine serum (FBS), and
the supplemental growth factors VEGF, bFGF, EGF, and
IGF. The arterial vessels attached to the substrata of the
culture dishes (BD Falcon; Becton Dickinson, San Jose,
CA). Cells migrated out from the surface of the tissues
after about 20 days of incubation at 37°C in 5% CO2.
The cells were harvested in PBS containing 0.1% trypsin
and 0.25 mM EDTA, and were re-seeded at a density of
3×1 0
5 cells in a 10-cm dish. Confluent monolayers of
cells were subcultured. The culture medium was
replaced every 3-4 days. Human uterine endometrium
(UtE) was harvested from a patient with endometriosis.
The endometrium was sterilized in PBS and cut into
small pieces with dissection scissors. These pieces were
placed in Dulbecco’s Modified Eagle’sM e d i u m( S i g m a
Chemical Co. St. Louis, MO), supplemented with 10%
FBS and an antibiotic-antimycotic (100×) solution (Invi-
trogen), and incubated for 10-14 days at 37°C in a
humidified 5% CO2 atmosphere. Subconfluent adherent
cells were harvested in PBS containing 0.06% trypsin
and 0.005% EDTA, and were subcultured. The culture
medium was replaced every 4 days. This study was
approved by the Ethical Committee of the National
Institute for Child Health and Development. The pur-
pose of this study was explained thoroughly to the
patients, who gave their written informed consent.
hiPSCs were cultivated on irradiated MEFs in iPSellon
medium (Cardio, Osaka, Japan), supplemented with 10
ng/ml recombinant human bFGF (Wako Pure Chemi-
cals, Osaka, Japan). hiPSCs were established from MRC-
5 and AM cells, as previously described [21,22]. In addi-
tion, hiPSCs were established from PAE and UtE cells in
the present study. Briefly, 1 × 10
5 cells were infected
overnight with pooled viral supernatants, obtained by
the transfection of HEK293FT cells (TransIT-293
reagent; Mirus, Madison, WI) with the retroviral vector
pMXs, which encodes the cDNAs for OCT3/4, SOX2,
KLF4, and c-MYC, together with the packaging plasmids
pCLGagPol and pHCMV-VEV-G (a gift from T. Kiyono,
National Cancer Center Research Institute, Tokyo,
Japan). Four days after infection, the cells were split, pla-
ted on irradiated MEFs in 100-mm dishes, and main-
tained in iPSellon medium until colonies formed.
The immunocytochemical analysis was performed as
described previously [22,23]. Human cells were fixed
with 4% paraformaldehyde in PBS for 10 min at 4 °C.
After washing with 0.1% Triton X-100 in PBS (PBST),
the cells were prehybridized in blocking buffer for 1–12
h at 4 °C, and then incubated for 6–12 h at 4°C with
the following primary antibodies: anti-SSEA4 (1 : 300
dilution; Chemicon, Temecula, CA), anti-TRA-1–60 (1 :
300; Chemicon), anti-Oct4 (1 : 50; Santa Cruz Biotech-
nology, Santa Cruz, CA), anti-Nanog (1 : 300; Repro-
CELL, Tokyo, Japan), and anti-Sox2 (1 : 300;
Chemicon). The cells were then incubated with anti-rab-
bit IgG, anti-mouse IgG or anti-mouse IgM conjugated
with Alexa Fluor 488 or Alexa Fluor 546 (1: 500; Mole-
cular Probes, Eugene, OR) in blocking buffer for 1 h at
room temperature. The cells were counterstained with
DAPI, and then mounted using a SlowFade light anti-
fade kit (Molecular Probes).
Teratoma formation was performed as described pre-
viously [22,23]. The 1:1 mixtures of the AM-hiPSC sus-
pension and Basement Membrane Matrix (BD
Biosciences, San Jose, CA) were implanted subcuta-
neously, at 1.0 × 10
7 cells / site, into immunodeficient,
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ficiency (SCID) mice (CREA, Tokyo, Japan). Teratomas
were surgically dissected out 6–10 weeks after implanta-
tion, and were fixed with 4% paraformaldehyde in PBS
and embedded in paraffin. Sections of 10-μmt h i c k n e s s
were stained with hematoxylin-eosin.
Gene expression analysis
Total RNA samples were extracted using ISOGEN (Nip-
ponGene). The global gene expression patterns and
changes in mRNA levels were monitored using Agilent
Whole Human Genome Microarray chips (G4112F)
with one-color (Cyanine 3) dye. This microarray chip
covers 41,000 well-characterized human genes and tran-
scripts. The raw microarray data were submitted to the
GEO (Gene Expression Omnibus) microarray data
archive (http://www.ncbi.nlm.nih.gov/geo/) at the NCBI
(accession number: GSE 20750). After background cor-
rection using a Normal plus Exponential convolution
model, which adjusts the foreground to the background,
we used an offset to dampen the variation of the log-
ratios for intensities close to zero.
Among the 41,000 probes, 16,483 representative
probes corresponding to MAQC unique genes were
used for the following analyses [44]. Global array clus-
tering was performed by the complete linkage method
with Euclidean distance, and was visualized using the
Java TreeView 1.1.0 software; the gene expression values
are displayed as normalized log ratios. Cell line similari-
ties were measured using Pearson correlation coeffi-
cients. To further validate whether the global gene
expression is different in each origin cell, we evaluated
the classification accuracy by leave-one-out cross-valida-
tion (LOOCV) on the nearest-neighbor classifier, based
on Pearson’s correlation distance. To obtain the expres-
sion signatures, we performed a differential analysis for
each origin cell: differences between the two arbitrary
datasets were evaluated by the Student’st - t e s tf o rt h e
expression of each gene. Thereafter, the false discovery
rate (FDR) was estimated using the Benjamini–Hoch-
berg procedure. Differentially expressed genes were
selected if they satisfied both FDR <0.05 and a 2.0-fold
change in the average values for the cell lines being
compared. The gene ontology analysis was performed
using the GO Term Finder Perl script [45] (http://go.
princeton.edu/cgi-bin/GOTermFinder), with EBI human
GO annotations and generic GO slim annotations
(http://www.geneontology.org/).
Network screening
Network screening was performed as described pre-
viously [21]. This analysis is based on the procedure for
estimating the consistency of a network structure (direc-
ted acyclic graph) with the measured data for the
constituent variables in the graph. The joint density
function for a given network (reference network) was
recursively factorized into conditional density functions,
according to the parent-child relationship in the graph.
The conditional functions were quantified into log-likeli-
hoods, using linear regression for the measured data,
with the assumption that the data followed a normal
distribution. The probability of the log-likelihood for the
network structure (graph consistency probability; GCP)
was then estimated from the distribution of log-likeli-
hoods for 2,000 networks, generated under the condi-
tion that the networks shared the same numbers of
nodes and edges as those of the given network. The sig-
nificance probability of the given network was set at
0.05 in this analysis.
In the present study, the GCP was estimated for the
ensemble of reference networks, to extract the candidate
activated networks in the hiPSCs, in a process termed
‘network screening’. The reference networks were con-
structed using the ChIP-on-Chip data and the classifica-
tion scheme for gene function. The genes bound by four
factors were cited from a previous report [20], and were
divided into sub-networks according to the functional
gene sets previously defined in the Molecular Signatures
Database (MSigDB) [24]. The sub-networks that
included at least one gene of the expression signature
were then selected. The set of selected sub-networks
was used as the reference network for network
screening.
Glycan analysis
We analyzed cell surface glycans with a lectin microar-
ray [31]. The 43 lectins were dissolved at a concentra-
tion of 0.5 mg/ml in spotting solution (Matsunami
Glass, Osaka, Japan), and were spotted onto epoxysi-
lane-coated glass slides (Nexterion Slide E Epoxysilane-
coated Substrate 25 × 75.6 × 1 mm; Schott, Mainz, Ger-
many) attached to a silicone rubber sheet, using a non-
contact microarray printing robot (MicroSys 4000;
Genomic Solutions, Ann Arbor, MI). The lectins were
spotted in triplicate, with a spot diameter of 500 μm.
The glass slides were incubated at 25°C for 3 h, to allow
lectin immobilization. The lectin-immobilized glass
slides were then washed with probing buffer (25 mM
Tris-HCl [pH 7.5], 140 mM NaCl, 2.7 mM KCl, 1 mM
CaCl2, 1 mM MnCl2, 1% [v/v] Triton X-100), and incu-
bated with the blocking reagent N102 (NOF, Tokyo,
Japan) at 20°C for 1 h. Finally, the lectin-immobilized
glass slides were flooded with TBS containing 0.1%
NaN3 and stored at 4°C. The cell membrane faction was
prepared using the CelLytic MEM Protein Extraction
Kit (Sigma-Aldrich, Tokyo, Japan), and the protein con-
centration was determined using the MicroBCA Protein
Assay Reagent kit (Thermo Fisher Scientific, Waltham,
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mM NaCl, 2.7 mM KCl, 1% Triton X-100), the cell
membrane fraction was labeled with Cy3 NHS ester (GE
Healthcare Ltd., Buckinghamshire, England). After dilu-
tion in probing buffer to the desired concentration, the
Cy3-labeled cell membrane fraction was applied to the
lectin microarray and incubated at 20°C overnight. After
washing with the probing buffer, fluorescence images
were acquired using an evanescent-field activated fluor-
escence scanner (SC-Profiler; GP BioScience, Kanagawa,
Japan). The fluorescence signal of each spot was quanti-
fied using the Array Pro Analyzer ver. 4.5 software
(Media Cybernetics, Bethesda, MD), and the background
value was subtracted. The values shown for the lectin
signals represent the average of triplicate spots.
Additional files
There are 14 additional files in the present analysis. For
convenience, we provide an overview of the additional
files. Additional files 1, 2, 3, 4, 5 are related to the cell
classification in Figure 1: the details of the cell lines and
their experimental establishment are described in files 1
and 2, and the details of the analyses of the expression
data are described in files 3-5. Additional figures 6-8 are
related to the gene expression signature in Figure 2: the
details of the analyzed data are described in files 6 and
7 ,a n dt h er e s u l t so b t a i n e db yas t a n d a r da n a l y s i sa r e
described in file 8. Additional files 9, 10, 11 are related
to the network signature in Figure 3: the methodological
aspects of the network screening are described in files 9
and 10, and in file 11, the detailed results are presented.
Additional files 12, 13, 14 are related to the glycan sig-
nature in Figure 5: all of the information for interpreting
the analyzed results is presented in the three files.
Additional material
Additional file 1: Cell lines and numbers of passages analyzed in
the present study. The following abbreviations are used for the human
somatic cell (SC) and induced pluripotent stem cell (hiPSC) sources: AM,
amniotic membrane; PAE, placental artery endothelial; UtE, uterine
endometrium; and MRC, MRC-5 cell line. The AM and MRC cell lines
were named previously [22,23]. The number of passages for each cell line
is indicated by the letter ‘p’ followed by an Arabic number.
Additional file 2: Generation of iPSCs from human PAE cells.( A) PAE
cells from the arterial endothelium of a human placenta (a), and
generation of hiPSCs through epigenetic reprogramming by retrovirus
infection-mediated expression of OCT4, SOX2, KLF4, and c-MYC (b). (B)
Expression patterns of the pluripotent cell markers, TRA-1-60, SSEA-4,
NANOG, OCT3/4, and SOX2. The cell nuclei were stained with DAPI. (C)
Hematoxylin-eosin staining of sections of teratomas generated by PAE-
hiPSC implantation. The histological examination revealed that the
tumors contain neural tissues (a: ectoderm), cartilage (b: mesoderm), and
a gut-like epithelial tissue (c: endoderm).
Additional file 3: Clustering for all cells by another method. Another
clustering was performed by the WARD method, instead of the complete
linkage method of Figure 1, with Euclidean distance, and was visualized
using the Java TreeView 1.1.0 software. The gene expression values are
displayed as normalized log ratios. The abbreviations used are the same
as those listed in Figure 1 and additional file 1.
Additional file 4: Correlation coefficient matrix for all cells. Pearson’s
correlation coefficients between 51 cells for the expression profiles of all
genes were calculated. The abbreviations used are the same as those
listed in Figure 1 and additional file 1.
Additional file 5: Cross-validation of cell classification. The
classification accuracy was evaluated by leave-one-out cross-validation
(LOOCV) on the nearest-neighbor classifier, based on the Pearson’s
correlation distance.
Additional file 6: Number matrix for common genes. The numbers of
genes that were different between the iPSCs and SCs are listed on the
diagonal of the matrix, and those that were shared between the four
gene sets that showed expression differences between the iPSCs are
listed above the diagonal. The abbreviations used are the same as those
listed in Figure 1.
Additional file 7: List of 2,502 genes in the expression signature,
together with the fold-changes in expression levels and FDR values.
The fold-change values are listed for the minimum values among the four
sets of comparisons between iPSCs and SCs (+, iPSCs>SCs; -, iPSCs<SCs),
and the FDR values shown are the maximum values among these sets.
Additional file 8: List of enriched GO terms with significant
probabilities (FWER < 0.05).
Additional file 9: Schematic representation of the procedure used to
obtain the network signature. The procedure for obtaining the network
signature from the expression signature is shown schematically. The
detailed procedure is as follows: 1) We first prepare the information for the
gene sets to which the transcriptional factors bind, as deduced from the
ChIP-on-chip experiments [20]; 2) Next, we prepare the information for the
gene sets that were classified using knowledge of biological functions
[24]; 3) The large gene sets in step 1 are divided into smaller subsets,
according to the classification scheme of the gene sets in step 2; 4) If at
least one gene in the expression signature is included in each gene subset
in step 3, then the subset is regarded as a reference network; 5) In each
reference network, the enrichment probability of the genes in the
expression signature is tested with a significance probability of 0.05. Thus,
we narrow down the network signature from the reference networks, in
terms of gene numbers; 6) The significant reference networks identified in
step 5 are further tested by calculating the graph consistency probability,
which assesses the consistency between the network structure and the
expression data for the constituent genes [24]. In this step, we further
refine the network signature, in terms of both the network structure and
the extent of gene expression; 7) Finally, we define the network signature,
using the reference networks that passed the tests in steps 5 and 6.
Additional file 10: Reference networks and constituent genes.
Additional file 11: Details of the network signature. The characters in
the above list are colored, according to the classification of biological
function shown in Figure 2A.
Additional file 12: Lectin-glycan-glycosyltransferase relationships
and correlations of lectin array intensities with glycosyltransferase
expression patterns. Lectins with FDR<0.05 are colored red. The
glycosyltransferases in the expression signature are indicated by a circle
in the column “Expression signature” in “Gene expression”. The Pearson’s
correlation coefficients between the lectin signal intensities and the
expression profiles of the corresponding glycosyltransferases are listed,
together with the significance probabilities. The original lectin array data
can be obtained by request to HT or JH.
Additional file 13: Knowledge-based relationships between
glycosyltransferases and their biosynthetic pathways.
Additional file 14: Locations of the glycosyltransferases detected in
the present study in the pathways of “Glycan Biosynthesis and
Metabolism”. The glycosyltransferases listed in Table 1 were allocated to
the pathways in “1.7 Glycan Biosynthesis and Metabolism” of the KEGG
GLYCAN program (http://www.genome.jp/kegg/pathway.html#glycan).
The glycosyltransferases and epitopes related to differentiation are
indicated by red-colored boxes and red lines, respectively, in each
pathway (see the text for details).
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